公司资料
Statera Biopharma 股价、新闻与催化剂
- 股票代码:
- STAB
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.00 USD (0.00%)
收盘价
最后更新: 2026年8月24日
—
市值
股价为何变动
As of Aug 24, 2026, STAB was little changed and closed at $0.0001. No new same-company headline was identified in the current news window.
公司概览
业务概览
Statera Biopharma was an immunotherapy and inflammation-focused biotechnology company that pursued immune modulation in difficult diseases. Its story was rooted in narrow development programs and the challenge of keeping a micro-cap platform alive.
所在地与行业分类
Statera is headquartered in the United States and listed on NASDAQ. It sits in small-cap immunology biotechnology.
商业模式特征
The company depended on clinical progress, restructuring, and capital preservation. Investors historically watched whether the platform could generate enough data to justify continued development.
生物医药行业定位
Statera occupies a historical micro-cap immunology niche within biotech. The stock was always highly sensitive to financing and program-level updates.
未来催化剂
- Statera is a legacy / closeout story, with catalysts limited to any remaining strategic or asset-resolution update. There is no active standalone growth story left.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。